THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH ...THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 2.66 Å3/Da / 溶媒含有率: 53.71 %
結晶化
温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7.2 詳細: 0.2000M NaFormate, 20.0000% PEG-3350, No Buffer pH 7.2, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
解像度: 2.25→32.126 Å / Num. obs: 26590 / % possible obs: 97.9 % / Observed criterion σ(I): -3 / Rmerge(I) obs: 0.068 / Net I/σ(I): 9.39
反射 シェル
解像度 (Å)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured obs
Num. unique obs
Diffraction-ID
% possible all
2.25-2.31
0.491
1.5
6395
3372
1
89.6
2.31-2.37
0.398
1.9
6819
3551
1
98.6
2.37-2.44
0.322
2.3
6794
3544
1
99.1
2.44-2.51
0.29
2.6
6502
3386
1
98.9
2.51-2.6
0.233
3.1
6353
3295
1
98.9
2.6-2.69
0.234
3.3
6140
3185
1
99.1
2.69-2.79
0.17
4.2
5990
3120
1
99
2.79-2.9
0.146
5.2
5703
2947
1
99.1
2.9-3.03
0.111
6.6
5501
2850
1
99.1
3.03-3.18
0.091
7.8
5185
2702
1
99
3.18-3.35
0.071
10.3
5053
2620
1
99.4
3.35-3.56
0.05
13.8
4638
2415
1
98.2
3.56-3.8
0.039
17.4
4439
2301
1
98.3
3.8-4.11
0.032
20.6
4116
2121
1
98.4
4.11-4.5
0.031
22.7
3816
1940
1
98.3
4.5-5.03
0.026
23.9
3356
1731
1
97.2
5.03-5.81
0.029
22.3
3082
1572
1
97.6
5.81-7.11
0.028
23.8
2520
1279
1
96.7
7.11-10.06
0.019
30.8
1998
1008
1
96.7
10.06-32.126
0.017
38.1
1048
528
1
93
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
REFMAC
5.5.0109
精密化
PHENIX
精密化
SHELX
位相決定
MolProbity
3beta29
モデル構築
XSCALE
データスケーリング
PDB_EXTRACT
3.006
データ抽出
XDS
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 多波長異常分散 / 解像度: 2.25→32.126 Å / Cor.coef. Fo:Fc: 0.954 / Cor.coef. Fo:Fc free: 0.934 / Occupancy max: 1 / Occupancy min: 0.37 / SU B: 13.9 / SU ML: 0.149 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.269 / ESU R Free: 0.204 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE ...詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 4. FORMATE (FMT) AND ETHYLENE GLYCOL (EDO) MODELED WERE PRESENT IN CRYSTALLIZATION OR CRYO CONDITIONS. 5. REGIONS OF POOR ELECTRON DENSITY:20-28,113-121, 197-203,226-236. MODEL AT THOSE REGIONS IS NOT RELIABLE.
Rfactor
反射数
%反射
Selection details
Rfree
0.227
1339
5 %
RANDOM
Rwork
0.185
-
-
-
obs
0.187
26590
99.23 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK